The COVID-19 pandemic brought messenger RNA (mRNA) vaccines to the forefront of global health care. After their clinical ...
A severe case of COVID-19 or influenza could increase the risk of lung cancer later on, according to new research. Scientists discovered that serious viral infections can alter immune cells in the ...
Peer-Reviewed Article Describes Clinical and Immunologic Rationale for Dual-Antigen MVA-Based Vaccine Designed to Address Limitations of First-Generation COVID-19 Vaccines in Highly Vulnerable ...
A topical cream that activates the skin’s immune defenses may slow or prevent the growth of common skin cancers.
A multi-disciplinary research team at the Wyss Institute at Harvard University, Dana-Farber Cancer Institute, and ...
A recent study has found that severe cases COVID-19 or influenza can leave lasting changes in the lungs that increase the ...
Wyss Institute's DoriVac combined vaccine and adjuvant technology uses nanoscale precision enabled by DNA origami to induce broad immunity against ...
Severe COVID-19 and influenza infections prime the lungs for cancer and can accelerate the disease’s development, but vaccination heads off those harmful effects, new research indicates.
Discover the molecular mechanisms behind severe blood clots linked to specific COVID-19 vaccines, revealing crucial insights for future vaccine safety.
Lingering inflammation from viruses like COVID-19 or HIV can take a lasting toll on the brain. New research shows exactly how specific immune system imbalances lead to memory lapses and slowed ...
Patients hospitalized with severe COVID-19 have an increased risk of developing lung cancer months or years later, according to new research from the University of Virginia.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results